|
Volumn 39, Issue 8, 2009, Pages 2044-2048
|
A clinical perspective of rheumatoid arthritis
|
Author keywords
Anti citrullinated protein antibodies; Anti mutated isoforms of citrullinated vimentin; Rheumatoid arthritis; Undifferentiated arthritis
|
Indexed keywords
ADALIMUMAB;
ATACICEPT;
AUTOANTIBODY;
BORTEZOMIB;
CERTOLIZUMAB PEGOL;
CYCLIC CITRULLINATED PEPTIDE ANTIBODY;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
GLUCOCORTICOID;
GOLIMUMAB;
HLA DR ANTIGEN;
INFLIXIMAB;
INTERLEUKIN 1;
INTERLEUKIN 6;
METHOTREXATE;
OCRELIZUMAB;
RITUXIMAB;
STAT4 PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;
UNCLASSIFIED DRUG;
VIMENTIN;
ANTIRHEUMATIC AGENT;
ATLIZUMAB;
IMMUNOGLOBULIN G;
INTERLEUKIN 6 RECEPTOR;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
ANTIBODY DETECTION;
ANTIBODY PRODUCTION;
BLOOD ANALYSIS;
CIGARETTE SMOKING;
DISEASE COURSE;
DISEASE MODEL;
DISEASE PREDISPOSITION;
DOPPLER ECHOGRAPHY;
DRUG TARGETING;
ENVIRONMENTAL FACTOR;
FAMILY STUDY;
GENETIC ASSOCIATION;
GENETIC RISK;
HERITABILITY;
HUMAN;
MEDICAL DECISION MAKING;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOGENESIS;
PRIORITY JOURNAL;
REMISSION;
REVIEW;
RHEUMATOID ARTHRITIS;
RISK FACTOR;
ANIMAL;
ARTICLE;
BIOLOGICAL MODEL;
DRUG ANTAGONISM;
FAMILY HEALTH;
GENETICS;
IMMUNOLOGY;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DISEASE MODELS, ANIMAL;
FAMILY HEALTH;
GENOME-WIDE ASSOCIATION STUDY;
HUMANS;
IMMUNOGLOBULIN G;
MODELS, BIOLOGICAL;
RECEPTORS, INTERLEUKIN-6;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 70249093284
PISSN: 00142980
EISSN: 15214141
Source Type: Journal
DOI: 10.1002/eji.200939514 Document Type: Review |
Times cited : (5)
|
References (38)
|